PROSION Therapeutics
Franz von Nussbaum is the Executive Vice President and Head of Life-Science Chemistry at Nuvisan Pharma Services since July 2020, focusing on innovation within the life sciences sector. Additionally, Franz serves as a Scientific Advisor at PROSION Therapeutics and holds a Lectureship in Medicinal Chemistry at Technische Universität Berlin. Prior experience includes various leadership roles at Bayer Pharmaceuticals, where responsibilities encompassed medicinal chemistry and drug discovery in oncology. Educationally, Franz obtained a Doctor of Philosophy in Chemistry from Ludwig-Maximilians-Universität München and completed postdoctoral studies in Organic Chemistry at Columbia University.
This person is not in any teams
PROSION Therapeutics
We are PROSION Therapeutics, a biotech & drug development company based in Germany that aims at making the undruggable druggable. Through our proprietary platform technology of LEGO-like chemical building blocks, we are able to develop new and effective drugs, targeting hard-to-treat diseases - starting with the most aggressive cancer forms.